BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26956379)

  • 1. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
    Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
    Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.
    Carter JM; Caron BL; Dogan A; Folpe AL
    Am J Surg Pathol; 2015 Jan; 39(1):75-83. PubMed ID: 25025444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
    Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
    Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors.
    Tajima S; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(7):8159-64. PubMed ID: 26339384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
    Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
    Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease.
    Hu F; Jiang C; Zhang Q; Shi H; Wei L; Wang Y
    Dis Markers; 2016; 2016():3176978. PubMed ID: 27034530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
    Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
    J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.
    Tajima S; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(8):9422-7. PubMed ID: 26464698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
    Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
    Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis.
    Uchihashi K; Nishijima-Matsunobu A; Matsuyama A; Yamasaki F; Tanabe T; Uemura T; Aragane N; Yakushiji M; Yamamoto M; Aoki S; Toda S
    Hum Pathol; 2013 Nov; 44(11):2614-8. PubMed ID: 23954138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
    Koga K; Iwasaki H; Nabeshima K
    J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors.
    Tajima S; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(8):9390-6. PubMed ID: 26464693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
    Kojima D; Ohba S; Abe M; Suzuki A; Horibe S; Tateya I; Hasegawa M; Hirose Y
    Neuropathology; 2022 Oct; 42(5):453-458. PubMed ID: 35880350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
    Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl: case report.
    Ellis MB; Gridley D; Lal S; Nair GR; Feiz-Erfan I
    J Neurosurg Pediatr; 2016 May; 17(5):573-7. PubMed ID: 26722864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23-Associated Tumor-Induced Osteomalacia in a Patient With Small Cell Carcinoma: A Case Report and Regulatory Mechanism Study.
    Sauder A; Wiernek S; Dai X; Pereira R; Yudd M; Patel C; Golden A; Ahmed S; Choe J; Chang V; Sender S; Cai D
    Int J Surg Pathol; 2016 Apr; 24(2):116-20. PubMed ID: 26612848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas.
    Graham R; Krishnamurthy S; Oliveira A; Inwards C; Folpe AL
    J Clin Pathol; 2012 Oct; 65(10):907-9. PubMed ID: 22933546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
    Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
    Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.